Grant: Engage Grants Program
University of Victoria
$25,000.00
Characterization and optimization of the ReLiver engineered liver tissue****
FY 2018-19
Summary
This project will initiate a first time collaboration between the Willerth laboratory at the University of Victoria*and Morphocell Technologies located in Quebec. Morphocell Technologies is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissues aimed at treating liver diseases. In particular, this project will enable further characterization and optimization of their ReLiver product - which consists of functional liver tissues derived from human induced pluripotent stem cells (hiPSCs) known as organoids. The ReLiver product consists hiPSC-derived liver tissues encapsulated inside of a poly (ethylene glycol) (PEG) coating that promotes biocomptability. This project will characterize the properties, including pore size, using scanning electron microscopy and will investigate alternative biomaterials formulations to improve the coating properties. Dr. Willerth has over 15 years of experience in the fields of biomaterials and stem cell-based tissue engineering, making her a logical partner for this project.*
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
536673-2018
Name nom
Willerth, Stephanie
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Characterization and optimization of the ReLiver engineered liver tissue****
Keyword
NSERC
Application summary
This project will initiate a first time collaboration between the Willerth laboratory at the University of Victoria*and Morphocell Technologies located in Quebec. Morphocell Technologies is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissues aimed at treating liver diseases. In particular, this project will enable further characterization and optimization of their ReLiver product - which consists of functional liver tissues derived from human induced pluripotent stem cells (hiPSCs) known as organoids. The ReLiver product consists hiPSC-derived liver tissues encapsulated inside of a poly (ethylene glycol) (PEG) coating that promotes biocomptability. This project will characterize the properties, including pore size, using scanning electron microscopy and will investigate alternative biomaterials formulations to improve the coating properties. Dr. Willerth has over 15 years of experience in the fields of biomaterials and stem cell-based tissue engineering, making her a logical partner for this project.*